Surrozen (Surrozen) Total Long-Term Assets : $4.70 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Surrozen Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Surrozen's Total Long-Term Assets for the quarter that ended in Mar. 2024 was $4.70 Mil.

Surrozen Total Long-Term Assets Historical Data

The historical data trend for Surrozen's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surrozen Total Long-Term Assets Chart

Surrozen Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Long-Term Assets

11.84

31.99

8.13

4.95

Surrozen Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Long-Term Assets	Get a 7-Day Free Trial										7.17	6.42	5.62	4.95	4.70

Surrozen Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Surrozen Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Surrozen's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Surrozen (Surrozen) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Surrozen Inc (NAS:SRZNW) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

SRZN:USA

Address

171 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080

Website

https://www.surrozen.com

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).